Sponsor

Changsha First Hospital

Clinical research sponsor

Published trials3

Recruiting shown1

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)NCT05598528 · collaborator · 2021-09-28

RECRUITING

ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLCNCT05198154 · collaborator · 2022-01-24

ACTIVE_NOT_RECRUITING

Effects of Particulate Matter on the Pulmonary Function and Acute Exacerbation of COPD and AsthmaNCT03193879 · collaborator · 2015-12-01

COMPLETED

Sponsor roles

collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.